Displaying 1 to 10 of 10 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. |
United States | N/A Active |
||
|
|
Eos Biotechnology Inc Next generation genomics company that uses the complete human genome to identify new drug targets and develop antibodies against those targets to trea |
United States | N/A |
||
|
|
Hydra Biosciences Inc |
United States | N/A |
||
|
|
Knopp Biosciences LLC A drug discovery and development company focused on delivering breakthrough treatments in neurological disorders |
United States | N/A |
||
|
|
MacroGenics Inc Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. |
United States | 12 May 2006 | Series C Active |
|
|
|
Optherion Inc |
United States | N/A |
||
|
|
Probiodrug Biopharmaceutical company focused on the development of innovative small molecule drugs. |
Germany | 1 Nov 2009 | Series B |
|
|
|
Probiodrug Biopharmaceutical company focused on the development of innovative small molecule drugs. |
Germany | 1 Jan 2012 | Venture |
|
|
|
Raven Biotechnologies Inc A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. |
United States | 12 Oct 2005 | Series D |
|
|
|
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. |
United States | 31 Dec 2008 | Series A |